Sort by
Refine Your Search
-
Category
-
Country
-
Program
-
Employer
-
Field
-
the Francis Crick Institute. This initiative brings together world-class experts in evolutionary genomics, stem cell biology, and computational science to unravel one of the most fascinating puzzles in
-
relapse. The group investigates the mechanisms underpinning this process using a human induced pluripotent stem cell (iPSC)-derived bone marrow organoid model engrafted with primary ALL cells, enabling
-
of stem cell-based therapies for Hirschsprung disease. About you You will hold a PhD degree in experimental biology, anatomy, physiology, neuroscience, or a relevant subject area and have evidence of first
-
, the Giustacchini group aim to develop stem-cell-based models of paediatric leukaemia to understand how malignant haematopoiesis interacts with the immune system and to improve responses to CAR T-cell therapy. We
-
DEADLINE: The next deadline is 31st August 2026, 5 pm. The Research Department of Cell and Developmental Biology (CDB) at University College London (UCL) invites Expressions of Interest from early
-
nearing PhD completion.* Strong experience in mammalian cell culture, ideally including stem-cell derived or complex in vitro systems.* Experience working with organoids, spheroids, assembloids, engineered
-
analysis, and comparative transcriptomic methods Experience/skills in imaging and image analysis, knock-out methods, electroporation, transgenics, in vitro stem cell models, and mechanical perturbation
-
We are focused on fostering education and training in research to develop microenvironments to investigate and instruct cellular behaviour including, but not solely, stem cell differentiation. Our
-
-022-00951-w Investigating the role of autophagy and mitochondrial function in leukaemic stem cells Supervisors: Vignir Helgason , Eric Kalkman Our lab is interested in biological processes
-
strategies forbrain repair following immunologically mediated injury (Multiple Sclerosis, Guillain-Barré syndrome) and spinal cord injury using glial/stem cell transplantation and antibody profiling